small molecule

ARICEPT

DONEPEZIL HYDROCHLORIDE

Loss of exclusivityOctober 2026latest FDA-listed patent expiry
CompanyEisaiView the full company profile on CliffBio

Drug detail

Brand nameARICEPT
Active ingredientDONEPEZIL HYDROCHLORIDE
Strength23MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2010
Marketing statusRX

Listed patents

PatentExpiresType
8481565October 2026product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found